Skip to main content
TipRanks
Go Ultimate75% OFF

Compare MARR S.p.A. (M6Z) vs. Competitors

0 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:M6ZMARR S.p.A.EUR 4.70EUR 332.29M14.49-46.28%―Unlock the DE:M6Z analyst price target with TipRanks PremiumDE:M6ZUnlock the DE:M6Z top-analyst price target with TipRanks Premium
IT:CPRDavide Campari-Milano SpAEUR 6.82EUR 12.37B29.6318.75%Strong BuyUnlock the IT:CPR analyst price target with TipRanks PremiumDE:M6Z vs IT:CPRUnlock the IT:CPR top-analyst price target with TipRanks Premium
IT:ORSOrsero SpAEUR 14.26EUR 251.15M10.09-18.13%Moderate BuyUnlock the IT:ORS analyst price target with TipRanks PremiumDE:M6Z vs IT:ORSUnlock the IT:ORS top-analyst price target with TipRanks Premium
IT:FFFine Foods & Pharmaceuticals N.T.M. SpAEUR 5.52EUR 134.92M-44.20-40.26%Moderate BuyUnlock the IT:FF analyst price target with TipRanks PremiumDE:M6Z vs IT:FFUnlock the IT:FF top-analyst price target with TipRanks Premium
IT:IWBItalian Wine Brands S.p.A.EUR 15.50EUR 146.54M10.41-28.90%Moderate BuyUnlock the IT:IWB analyst price target with TipRanks PremiumDE:M6Z vs IT:IWBUnlock the IT:IWB top-analyst price target with TipRanks Premium
IT:NWLNewPrinces S.p.A.EUR 25.30EUR 1.08B4.2332.32%Moderate BuyUnlock the IT:NWL analyst price target with TipRanks PremiumDE:M6Z vs IT:NWLUnlock the IT:NWL top-analyst price target with TipRanks Premium

Performance Comparison

-60%-40%-20%0%20%40%60%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:M6ZMARR S.p.A.4.70-3.96-45.72%
IT:CPRDavide Campari-Milano SpA6.821.2622.74%
IT:ORSOrsero SpA14.26-2.27-13.73%
IT:FFFine Foods & Pharmaceuticals N.T.M. SpA5.52-3.58-39.35%
IT:IWBItalian Wine Brands S.p.A.15.50-5.66-26.73%
IT:NWLNewPrinces S.p.A.25.306.8437.05%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts